This is a scale-and-quality
rerating case, not a moonshot. AV already has real demand,
funded backlog and credible franchises in strike,
ISR and
counter-drone. If it proves
backlog conversion, keeps adding newer programs like
LOCUST and
Titan, and uses allied localization plus sustainment to smooth revenue, investors can value it more like a scaled defense-autonomy integrator than a one-program hardware name.